Nuevolution A/S announces a new CEO

08-Sep-2005

Nuevolution A/S announced that Knud Aunstrup is stepping down as the company's CEO and that he will be replaced in the position by Alex Haahr Gouliaev. The new management team of Nuevolution now comprises Alex Haahr Gouliaev (CEO), Henrik Pedersen (CSO) and Mark Payne (CFO).Knud Aunstrup will remain as an adviser to Nuevolution for the coming months.

Nuevolution's new CEO, Alex Haahr Gouliaev PhD (39), has a strong background as a medicinal chemist. Before joining Nuevolution as co-founder in 2001 with responsibility for Chemistry and Drug Discovery, he was Director of Chemistry and member of management at Denmark's largest biotech company, Neurosearch A/S.

Other news from the department people

Most read news

More news from our other portals

Fighting cancer: latest developments and advances